TCR Solutions Single Cell Discoveries offers an end-to-end TCR single-cell sequencing solution (sample processing through immune repertoire profiling and bioinformatics) leveraging 10x Genomics technology. This positions SCD to target immuno-oncology, autoimmune, and cell therapy programs, with opportunities to co-market with ecosystem partners and upsell adjacent multi-omics and spatial transcriptomics offerings.

Strategic Partnerships The company already collaborates with MLM Medical Labs, Genovis AB, Immunewatch, and participates in the PERSIST-SEQ consortium, plus holds European certification with BioSkryb ResolveServices. These relationships create multiple joint-sell and referral paths into US and EU clients and can be leveraged to expand cross-border sequencing and logistics services.

Certification Advantage Being a European Certified Service Provider for BioSkryb ResolveServices provides a credibility edge for regulated studies and data-quality focused customers. Use this certification in proposals to win EU-funded and compliant sequencing engagements with standardized workflows.

Logistics Readiness The MLM Medical Labs partnership demonstrates SCD’s capability to streamline cross-border sample shipping from the US, suggesting opportunities to offer turnkey logistics-backed sequencing projects to US biopharma and academic researchers seeking seamless study execution.

Growth Opportunities As a specialized CRO focused on single-cell, spatial, and multi-omics, SCD can pursue tiered service offerings, expand into EU and US markets, and partner with larger CROs for larger-scale projects while continuing to serve biopharma, health systems, and academic customers with targeted upsell of advanced omics services.